Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.43 USD
Change Today -0.34 / -19.21%
Volume 1.2M
OCLS On Other Exchanges
Symbol
Exchange
OCLS is not on other exchanges.
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - oculus innovative sciences i (OCLS)

NameBoard RelationshipsTitleAge
James Schutz 4 RelationshipsChief Executive Officer, President and Director52
Robert E. Miller No RelationshipsChief Operating Officer, Chief Financial Officer, Principal Accounting Officer and Corporate Secretary73
Robert Northey Ph.D.No RelationshipsExecutive Vice President of Research and Development58
Dan McFadden No RelationshipsDirector of Public & Investor Relations--
Bruce Thornton No RelationshipsExecutive Vice President of International Operations & Sales51

Board Members - oculus innovative sciences i (OCLS)

NameBoard RelationshipsPrimary CompanyAge
James Schutz 4 RelationshipsOculus Innovative Sciences, Inc.52
John G. McLaughlin 4 RelationshipsOculus Innovative Sciences, Inc.67
Russell Harrison 4 RelationshipsOculus Innovative Sciences, Inc.70
Sharon A. Surrey-Barbari 4 RelationshipsCytokinetics, Incorporated61
Jay Edward Birnbaum Ph.D.45 RelationshipsOculus Innovative Sciences, Inc.70

Executive Committees* - oculus innovative sciences i (OCLS)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeSharon A. Surrey-Barbari 4 Relationships3 Executives
Compensation CommitteeJohn G. McLaughlin 4 Relationships2 Executives
Nominating CommitteeRussell Harrison 4 Relationships2 Executives
Corporate Governance CommitteeRussell Harrison 4 Relationships2 Executives
View OCLS Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCLS:US $1.43 USD -0.34

OCLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astellas Pharma Inc ¥1,867 JPY +15.00
Henry Schein Inc $147.98 USD +1.22
Integra LifeSciences Holdings Corp $64.13 USD +0.13
Patterson Cos Inc $50.16 USD +0.39
Smith & Nephew PLC 1,189 GBp +22.00
View Industry Companies
 

Industry Analysis

OCLS

Industry Average

Valuation OCLS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.7x
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCULUS INNOVATIVE SCIENCES I, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.